CEO selling at CannTrust Holdings (TRST)

CEO selling at CannTrust Holdings (T:TRST)

Eric Paul, CEO and Director, disposed of 409,091 Common Shares on a control or direction basis for registered holder The Paul Family Trust at a price of US$5.500 through a prospectus or prospectus exempt offering on May 14th, 2019. This represents a $3,030,526 divestment of the company's shares and an account share holdings change of -4.4%.

CannTrust Holdings is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

CannTrust Holdings Inc is a Canada-based company, which produces pharmaceutical-grade medical cannabis for patients. The Company is a federally regulated licensed producer of medical cannabis products. The Company operates a hydroponic facility and an onsite laboratory for testing and research on the medical use of cannabis. The Company's exclusive pharmaceutical partner is Apotex. CannTrust Holdings Inc's products are divided into the following: Products Type, such as oil, dried cannabis, accessories and patient ready; Strain Type, such as hybrid, sativa dominant and indica dominant, as well as Strength, such as strong, mild and moderate. The Company's products are sold online through its Website. CannTrust Holdings Inc. (TRST) has below median officer and director direct ownership compared to its mid-cap peers in the market, based on our estimate using SEDI data. According to regulatory filings yesterday, one insider has divested a net amount of $3,030,526.